Adil Mohamed
Overview
Explore the profile of Adil Mohamed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
540
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Menendez C, Mohamed A, Perez-Lemus G, Weiss A, Rawe B, Liu G, et al.
Molecules
. 2023 Sep;
28(18).
PMID: 37764425
Recently, a high-throughput screen of 1900 clinically used drugs identified masitinib, an orally bioavailable tyrosine kinase inhibitor, as a potential treatment for COVID-19. Masitinib acts as a broad-spectrum inhibitor for...
2.
Chandran A, Sakthivel P, Thakar A, Mohamed A
Postgrad Med J
. 2023 Apr;
98(e1):e20-e21.
PMID: 37066571
No abstract available.
3.
Mohamed A, Lin Q, Eaton H, Shmulevitz M
J Virol
. 2023 Feb;
97(2):e0000923.
PMID: 36744961
Mammalian orthoreovirus serotype 3 Dearing is an oncolytic virus currently undergoing multiple clinical trials as a potential cancer therapy. Previous clinical trials have emphasized the importance of prescreening patients for...
4.
Nguyen L, Renner D, Silva D, Yang D, Parenti N, Medina K, et al.
mBio
. 2022 Sep;
13(5):e0241522.
PMID: 36125275
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has killed over 6 million individuals worldwide and continues to spread in countries where vaccines are not yet widely available or its citizens...
5.
Nguyen L, Renner D, Silva D, Yang D, Parenti N, Medina K, et al.
bioRxiv
. 2022 Jul;
PMID: 35821981
Importance: SARS-CoV-2 is the third lethal respiratory coronavirus after MERS-CoV and SARS-CoV to emerge this century, causing millions of deaths world-wide. Other common coronaviruses such as HCoV-OC43 cause less severe...
6.
Nguyen L, Yang D, Nicolaescu V, Best T, Gula H, Saxena D, et al.
Sci Adv
. 2022 Jan;
8(8):eabi6110.
PMID: 35050692
The spread of SARS-CoV-2 and ongoing COVID-19 pandemic underscores the need for new treatments. Here we report that cannabidiol (CBD) inhibits infection of SARS-CoV-2 in cells and mice. CBD and...
7.
Perelman S, James D, Boguslawski K, Nelson C, Ilmain J, Zwack E, et al.
Nat Microbiol
. 2021 Apr;
6(6):731-745.
PMID: 33875847
Staphylococcus aureus has evolved into diverse lineages, known as clonal complexes (CCs), which exhibit differences in the coding sequences of core virulence factors. Whether these alterations affect functionality is poorly...
8.
Jones B, Brown-Augsburger P, Corbett K, Westendorf K, Davies J, Cujec T, et al.
Sci Transl Med
. 2021 Apr;
13(593).
PMID: 33820835
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a public health threat for which preventive and therapeutic agents are urgently needed. Neutralizing antibodies are a key class of therapeutics that may...
9.
Nguyen L, Yang D, Nicolaescu V, Best T, Ohtsuki T, Chen S, et al.
bioRxiv
. 2021 Mar;
PMID: 33758843
The rapid spread of COVID-19 underscores the need for new treatments. Here we report that cannabidiol (CBD), a compound produced by the cannabis plant, inhibits SARS-CoV-2 infection. CBD and its...
10.
Panda S, Mohamed A, Sikka K, Kanodia A, Sakthivel P, Thakar A, et al.
Indian J Otolaryngol Head Neck Surg
. 2020 Oct;
73(1):72-77.
PMID: 33078125
This study endeavours to comprehensively the study the spectrum of ENT manifestations in mild and asymptomatic COVID-19 and observe the natural course of anosmia and dysgeusia consequent to SARS-Cov-2 infection....